Brand Name(s): Desyrel; Trazon; Trialodine
CAS nº: 19794-93-5
(trah zoe done)

About Trazodone

This new site is dedicated exclusively to trazodone.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumers or pharma industry professionals, you can now find out everything you need to know about trazodone, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total trazodone experience! 

Why is this medication prescribed?

Trazodone is an antidepressant medication. It works by changing the actions of chemicals in the brain.

Trazodone is used to relieve symptoms of depression such as feelings of sadness, worthlessness, or guilt; loss of interest in daily activities; changes in appetite; tiredness; sleeping too much; insomnia; and thoughts of death or suicide.

As well as those mentioned above, some other trazodone brand names include Trittico® and Thombran®.

See more Product Info

Latest News

Acute Pisa Syndrome and Pharnygolaryngeal Dystonia Due to Ziprasidone

Case Report: Mr. A, a 20-year-old Caucasian male, was admitted for exacerbation of schizoaffective...

[more]

Labopharm Phase III Trial with Trazodone Hits Mark

After more than a year of FDA appeals regarding its once-daily formulation of the analgesic...

[more]

TSX climbs heading into weekend

The S&P/TSX Composite was up 63.97 points or 0.49% to 12989.34 on Friday.

[more]

Labopharm enters into agreement for US$25 million debt financing

Labopharm Inc. today announced that, through its U.S. subsidiary, it has entered into an agreement...

[more]

Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug

Labopharm Inc. today announced that it has completed patient enrolment in its North American Phase...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.